NASDAQ:LVGO Livongo Health Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Livongo Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $139.77 0.00 (0.00 %) (As of 10/30/2020) Add Compare Share Today's Range$139.77Now: $139.77▼$139.7750-Day Range$136.67MA: $140.45▼$148.0852-Week Range$18.76Now: $139.77▼$151.05VolumeN/AAverage Volume3.04 million shsMarket Capitalization$14.20 billionP/E RatioN/ADividend YieldN/ABeta1.81 ProfileAnalyst RatingsDividendEarningsInsider TradesInstitutional OwnershipHeadlinesShort InterestSocial Media Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.Read More MarketRank™Overall MarketRank™1.19 out of 5 starsMedical Sector821st out of 1,928 stocksComputer Programming, Data Processing, & Other Computer Related Industry37th out of 74 stocksAnalyst Opinion: 1.3Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 - 1.3 Analyst's Opinion Consensus RatingLivongo Health has received a consensus rating of Buy. The company's average rating score is 2.63, and is based on 10 buy ratings, 6 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $110.94, Livongo Health has a forecasted downside of 20.6% from its current price of $139.77.Amount of Analyst CoverageLivongo Health has only been the subject of 3 research reports in the past 90 days. Previous Next 3.2 Community Rank Outperform VotesLivongo Health has received 102 “outperform” votes. (Add your “outperform” vote.)Underperform VotesLivongo Health has received 56 “underperform” votes. (Add your “underperform” vote.)Community SentimentLivongo Health has received 64.56% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Livongo Health and other stocks. Vote “Outperform” if you believe LVGO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LVGO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldLivongo Health does not currently pay a dividend.Dividend GrowthLivongo Health does not have a long track record of dividend growth. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Livongo Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 13.00% of the stock of Livongo Health is held by insiders.Percentage Held by Institutions41.67% of the stock of Livongo Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Livongo Health are expected to grow in the coming year, from ($0.06) to $0.10 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Livongo Health is -349.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Livongo Health is -349.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLivongo Health has a P/B Ratio of 26.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer programming, data processing, & other computer related Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LVGO Previous Symbol CUSIPN/A CIKN/A Webwww.livongo.com Phone866-435-5643Employees471 Debt Debt-to-Equity Ratio0.69 Current Ratio19.88 Quick Ratio19.51Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$170.20 million Price / Sales83.42 Cash FlowN/A Price / Cash FlowN/A Book Value$5.37 per share Price / Book26.03Profitability EPS (Most Recent Fiscal Year)($1.01) Net Income$-55,270,000.00 Net Margins-12.20% Return on Equity0.29% Return on Assets0.21%Miscellaneous Outstanding Shares101,585,000Market Cap$14.20 billion Next Earnings Date3/1/2021 (Estimated) OptionableNot Optionable Receive LVGO News and Ratings via Email Sign-up to receive the latest news and ratings for LVGO and its competitors with MarketBeat's FREE daily newsletter. Livongo Health (NASDAQ:LVGO) Frequently Asked Questions Is Livongo Health a buy right now? 16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Livongo Health in the last twelve months. There are currently 6 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Livongo Health stock. View analyst ratings for Livongo Health or view MarketBeat's top 5 stock picks. What stocks does MarketBeat like better than Livongo Health? Wall Street analysts have given Livongo Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Livongo Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. What is Doug Parker's approval rating as Livongo Health's CEO? 1,428 employees have rated Livongo Health CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 59% among Livongo Health's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. When is Livongo Health's next earnings date? Livongo Health is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021. View our earnings forecast for Livongo Health. How were Livongo Health's earnings last quarter? Livongo Health, Inc. (NASDAQ:LVGO) announced its quarterly earnings data on Wednesday, October, 28th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.11. The firm had revenue of $106.10 million for the quarter, compared to the consensus estimate of $95.57 million. Livongo Health had a positive return on equity of 0.29% and a negative net margin of 12.20%. View Livongo Health's earnings history. How often does Livongo Health pay dividends? What is the dividend yield for Livongo Health? Livongo Health declared a dividend on Wednesday, October 21st. Stockholders of record on Thursday, October 29th will be given a dividend of $7.09 per share on Tuesday, November 3rd. The ex-dividend date is Monday, November 2nd. View Livongo Health's dividend history. What price target have analysts set for LVGO? 16 Wall Street analysts have issued 1-year price objectives for Livongo Health's shares. Their forecasts range from $46.00 to $170.00. On average, they anticipate Livongo Health's share price to reach $110.94 in the next year. This suggests that the stock has a possible downside of 20.6%. View analysts' price targets for Livongo Health or view Wall Street analyst' top-rated stocks. Who are some of Livongo Health's key competitors? Some companies that are related to Livongo Health include Pinterest (PINS), The Trade Desk (TTD), Twitter (TWTR), IHS Markit (INFO), Yandex (YNDX), GDS (GDS), Wix.com (WIX), LINE (LN), FactSet Research Systems (FDS), Weibo (WB), Dada Nexus (DADA), OneConnect Financial Technology (OCFT), Chindata Group (CD), Medallia (MDLA) and HUYA (HUYA). View all of LVGO's competitors. What other stocks do shareholders of Livongo Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Livongo Health investors own include NVIDIA (NVDA), Teladoc Health (TDOC), DocuSign (DOCU), Tesla (TSLA), Square (SQ), PayPal (PYPL), salesforce.com (CRM), Zoom Video Communications (ZM), CrowdStrike (CRWD) and Fastly (FSLY). Who are Livongo Health's key executives? Livongo Health's management team includes the following people: Mr. Glen E. Tullman, Founder & Exec. Chairman (Age 59)Dr. Jennifer Schneider, Pres (Age 44)Mr. James Pursley, Chief Commercial Officer (Age 39)Mr. Zane M. Burke, CEO & Director (Age 53)Mr. Lee A. Shapiro, Chief Financial Officer (Age 63) When did Livongo Health IPO? (LVGO) raised $230 million in an IPO on Thursday, July 25th 2019. The company issued 10,700,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan acted as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers. What is Livongo Health's stock symbol? Livongo Health trades on the NASDAQ under the ticker symbol "LVGO." What is Livongo Health's stock price today? One share of LVGO stock can currently be purchased for approximately $139.77. How big of a company is Livongo Health? Livongo Health has a market capitalization of $14.20 billion and generates $170.20 million in revenue each year. The company earns $-55,270,000.00 in net income (profit) each year or ($1.01) on an earnings per share basis. Livongo Health employs 471 workers across the globe. What is Livongo Health's official website? The official website for Livongo Health is www.livongo.com. How can I contact Livongo Health? Livongo Health's mailing address is 150 WEST EVELYN AVENUE SUITE 150, MOUNTAIN VIEW CA, 94041. The company can be reached via phone at 866-435-5643 or via email at [email protected] This page was last updated on 1/21/2021 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here
